Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Post by Trademark11on Apr 27, 2021 5:04am
1624 Views
Post# 33072631

Q2 Projection reposted

Q2 Projection reposted****Calculations in CAD for comparison purposes only****

3 aquisitions will contribute to Q2/21 revenue: 

     
     HTR (Full quarter),
     Sleepwell (Full quarter),
     Mayhew (2/3 quarter)

                     
Assumptions: 8 % organic growth for core business, HTR and Sleepwell. 
                         Flat (0%) organic growth for Mayhew


Q2/20 Revenue:                  24.1  Mil CAD x 1.08  =                    $26.3  Mil  CAD
HTR Revenue:                      5.5   Mil CAD x 1.08  x 1/4 =            $1.57 Mil  CAD
Sleepwell Revenue:           13.0   Mil CAD x 1.08 x 1/4 =             $3.51 Mil  CAD
Mayhew Revenue:               7.0    Mil CAD x 1/6 =                       $ 1.17 Mil CAD


                                                            Total Revenue:         $ 32.55 Mil CAD

                                                 Yr/Yr Growth in Revenue:                    35%


                   Projected Adj EBITDA @ 22% (assumed):               $7.2 Mil CAD
                                                                                               ( Annualized  $ 28.8 Mil CAD) 

                                                  Yr/Yr Growth in EBITDA:                     47%       
                                                                                        
                                        Annualized  Adj EBITDA/ share:              $ 0.23 CAD


Present multiple given to SP assuming zero growth for next 3 quarters:     8.4x
<< Previous
Bullboard Posts
Next >>